2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0...
Transcript of 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0...
Verein für Association pour le Associazione per il
medizinische Qualitätskontrolle contrôle de qualité médical controllo di qualità medico
MQ, Institut für Klinische Chemie, Universitätsspital Zürich, 8091 Zürich Telefon 044/255 34 11, Telefax 044/261 12 83, www.mqzh.ch, [email protected]
Survey Report
2015 - 1
Survey Specimens The homogeneity and stability of all specimens were checked before and/or during shipment and no irregularities were noted. The suitability tests were performed by the laboratories of the Universitätsspital Zürich (University Hospital Zurich) (http://www.uzl.usz.ch/). The following survey specimens were produced specifically for MQ by a sub-contractor: B1 Strep A Test, B2 Uricult, H4 Parasitic Hematology, K14 tumor marker Determination of target values For each target value, the type of determination per ISO17043: 2010 B2.1 is indicated (column "type"): a Value known due to production. b Certified reference value for use with special specimens c Reference value determined by analysis d Consensus values of expert laboratories e Consensus values of the participants For methods groups with more than 9 participants, consensus values of the participants ("e") are generally determined. In order to provide all participants with target values that are as meaningful as possible, other methods may also be applied for smaller method groups. Uncertainty of the determined target values The standard uncertainty (ux) is calculated using the following formula (ISO13528): ux = (target value/100) * (1.25/square root of "number of participants") * %CV
ux has the same unit as the target value ux can be compared with the standard deviation of the participants' collective (SD=target value*%CV/100) For participant numbers >18, the standard uncertainty (ux) is significantly lower than the scatter of the collective
participants and can be neglected.
QUALAB and MQ tolerances
For all mandatory analyzes, QUALAB tolerances are used (www.qualab.ch, external quality control). For non-mandatory analyzes, the tolerances are specified by MQ's survey specimen leader. If the determined uncertainty, ux, of the target value is greater than 15% of the QUALAB or MQ tolerance, the letter indicating the type of target detection is marked with an additional star (example "e*"). Thereby, we are alerting the participants to the fact that the uncertainty of the target value can have an impact on the evaluation.
Graphics
The results are shown graphically as follows:
lower Qualab limit80% of the results
50% of the results
lowestvalue
target value
highestvalue
upper Qualab limit
Comparison of Devices The data in this report allows you to compare the performance of different devices. However, remember to consider the following: The chemical control K1 is a ready-to-use commercial control serum. Even if the specimen is of human origin, it is possible
that matrix effects occur. These are device-specific and result in different target values. Only one specimen was measured. Since the scatter of the results is dependent on the nature of the specimen (matrix
effects) and on the signal strength, the determined coefficient of variations (CV in %) cannot be applied generally. A large number of runaways is due to administrative errors (wrong unit, results mixed up) or to operator errors (wrong
sample, not correctly taken up in solution, not mixed well) and has nothing to do with the type of device. .
Zürich, 30.3.2015
Dr. R. Fried Suvey Director Publication of this report or any portion thereof without our prior written consent is not permitted. The
original is archived at www.mqzh.ch .
Hemoglobin
H1 Hematology
QUALAB tolerance : 9 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Automat 54 88.8 5.6 5.6 106.0 3.7 e
2 Cyanmethemoglobin 53 92.4 3.8 3.8 105.7 3.5 e
3 Sysmex XT/XE/XS 39 100.0 0.0 0.0 106.7 1.2 e
4 ABX Pentra 11 100.0 0.0 0.0 105.9 2.4 e
5 Reflotron 83 86.8 8.4 4.8 108.9 5.1 e
6 Hemocue 337 95.2 0.9 3.9 105.3 2.6 e
7 Dr. Lange 24 95.8 0.0 4.2 106.7 4.2 e
8 Hemocontrol 12 91.7 0.0 8.3 108.1 1.6 e
9 Eurolyser 5 100.0 0.0 0.0 107.0 3.6 e*
10 Other methods 6 83.3 16.7 0.0 111.0 5.9 e*
90 94 98 102 106 110 114 118 122 126 130
Hemoglobin (g/l)
1
2
3
4
5
6
7
8
9
10
MQ 2015/1 Page 3/181
Hemoglobin
H1 Hematology
QUALAB tolerance : 9 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Abx Micros 917 95.3 1.2 3.5 104 2.9 e
2 Microsemi 202 98.5 0.0 1.5 105 2.1 e
3 Sysmex KX21 446 97.1 0.4 2.5 106 1.9 e
4 Sysmex PocH - 100i 219 96.8 0.9 2.3 104 2.5 e
5 Sysmex XP 300 148 98.6 0.0 1.4 108 1.6 e
6 Mythic 244 95.9 0.8 3.3 101 3.6 e
7 Swelab 68 95.6 1.5 2.9 108 2.8 e
8 MS4 8 100.0 0.0 0.0 102 4.5 e*
9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e
10 Medonic 19 100.0 0.0 0.0 106 3.8 e
11 Nihon Kohden Celltac 34 97.1 0.0 2.9 104 2.9 e
12 Samsung HC10 42 97.6 0.0 2.4 104 3.0 e
85 89 93 97 101 105 109 113 117 121 125
Hemoglobin (g/l)
1
2
3
4
5
6
7
8
9
10
11
12
MQ 2015/1 Page 4/181
Hematocrit
H1 Hematology
QUALAB tolerance : 9 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Automat 47 70.2 21.3 8.5 0.30 6.8 e
2 Centrifuge 16 87.5 12.5 0.0 0.31 5.3 e*
3 Sysmex XT/XE/XS 38 100.0 0.0 0.0 0.30 2.1 e
4 ABX Pentra 11 100.0 0.0 0.0 0.28 3.5 e
0.240 0.251 0.262 0.273 0.284 0.295 0.306 0.317 0.328 0.339 0.350
Hematocrit (l/l)
1
2
3
4
MQ 2015/1 Page 5/181
Hematocrit
H1 Hematology
QUALAB tolerance : 9 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Abx Micros 918 91.2 3.9 4.9 0.28 4.2 e
2 Microsemi 201 98.0 1.0 1.0 0.28 2.5 e
3 Sysmex KX21 446 96.9 1.3 1.8 0.28 2.5 e
4 Sysmex PocH - 100i 219 95.4 0.9 3.7 0.30 2.9 e
5 Sysmex XP 300 144 98.6 0.0 1.4 0.28 1.7 e
6 Mythic 244 95.5 2.5 2.0 0.29 4.0 e
7 Swelab 68 92.7 2.9 4.4 0.29 3.8 e
8 MS4 8 75.0 25.0 0.0 0.28 6.6 e*
9 Abacus Junior 12 91.7 8.3 0.0 0.31 4.4 e*
10 Medonic 19 94.7 0.0 5.3 0.29 3.4 e
11 Nihon Kohden Celltac 34 97.1 0.0 2.9 0.29 2.7 e
12 Samsung HC10 42 97.6 0.0 2.4 0.31 3.1 e
0.230 0.242 0.254 0.266 0.278 0.290 0.302 0.314 0.326 0.338 0.350
Hematocrit (l/l)
1
2
3
4
5
6
7
8
9
10
11
12
MQ 2015/1 Page 6/181
Erythrocytes
H1 Hematology
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Automat 46 97.8 2.2 0.0 3.45 6.9 e
2 Microscopic 9 100.0 0.0 0.0 3.20 13.9 e*
3 Sysmex XT/XE/XS 39 100.0 0.0 0.0 3.42 1.7 e
4 ABX Pentra 11 100.0 0.0 0.0 3.42 2.3 e
2.0 2.3 2.6 2.9 3.2 3.5 3.8 4.1 4.4 4.7 5.0
Erythrocytes (T/l)
1
2
3
4
MQ 2015/1 Page 7/181
Erythrocytes
H1 Hematology
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Abx Micros 918 97.6 0.7 1.7 3.3 5.1 e
2 Microsemi 204 98.5 1.5 0.0 3.3 4.7 e
3 Sysmex KX21 446 98.0 0.4 1.6 3.4 3.3 e
4 Sysmex PocH - 100i 219 97.7 0.5 1.8 3.5 3.4 e
5 Sysmex XP 300 147 98.6 0.7 0.7 3.4 2.8 e
6 Mythic 244 98.0 0.8 1.2 3.3 4.4 e
7 Swelab 68 98.5 1.5 0.0 3.4 4.8 e
8 MS4 8 100.0 0.0 0.0 3.4 5.0 e
9 Abacus Junior 12 100.0 0.0 0.0 3.6 4.3 e
10 Medonic 19 100.0 0.0 0.0 3.4 3.5 e
11 Samsung HC10 42 100.0 0.0 0.0 3.4 4.3 e
12 Nihon Kohden Celltac 34 97.1 2.9 0.0 3.5 7.1 e
1.5 1.9 2.3 2.7 3.1 3.5 3.9 4.3 4.7 5.1 5.5
Erythrocytes (T/l)
1
2
3
4
5
6
7
8
9
10
11
12
MQ 2015/1 Page 8/181
Leucocytes
H1 Hematology
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Automat 42 95.2 2.4 2.4 5.96 8.9 e
2 Microscopic 62 87.1 4.8 8.1 5.29 14.7 e
3 Sysmex XT/XE/XS 39 100.0 0.0 0.0 6.00 3.0 e
4 ABX Pentra 11 100.0 0.0 0.0 5.78 7.0 e
3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0
Leucocytes (G/l)
1
2
3
4
MQ 2015/1 Page 9/181
Leucocytes
H1 Hematology
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Abx Micros 918 98.9 0.7 0.4 5.46 5.5 e
2 Microsemi 204 99.5 0.5 0.0 5.59 4.3 e
3 Sysmex KX21 446 99.3 0.0 0.7 5.64 3.4 e
4 Sysmex PocH - 100i 219 98.2 0.0 1.8 5.69 4.1 e
5 Sysmex XP 300 148 99.3 0.0 0.7 5.87 3.6 e
6 Mythic 241 99.2 0.0 0.8 5.59 6.3 e
7 Nihon Kohden Celltac 34 100.0 0.0 0.0 5.82 4.5 e
8 Swelab 68 98.5 1.5 0.0 6.07 6.3 e
9 MS4 8 100.0 0.0 0.0 6.01 11.3 e*
10 Abacus Junior 12 100.0 0.0 0.0 7.03 7.6 e
11 Medonic 19 100.0 0.0 0.0 6.05 5.9 e
12 Samsung HC10 42 97.6 0.0 2.4 5.58 3.0 e
3.0 3.7 4.4 5.1 5.8 6.5 7.2 7.9 8.6 9.3 10.0
Leucocytes (G/l)
1
2
3
4
5
6
7
8
9
10
11
12
MQ 2015/1 Page 10/181
Thrombocytes
H1 Hematology
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Automat 39 100.0 0.0 0.0 233.4 10.4 e
2 Microscopic 37 86.5 13.5 0.0 216.0 14.1 e
3 Sysmex XT/XE/XS 39 100.0 0.0 0.0 228.2 2.6 e
4 Advia 120 4 100.0 0.0 0.0 219.5 4.4 e
5 ABX Pentra 11 100.0 0.0 0.0 251.5 5.9 e
140 160 180 200 220 240 260 280 300 320 340
Thrombocytes (G/l)
1
2
3
4
5
MQ 2015/1 Page 11/181
Thrombocytes
H1 Hematology
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Abx Micros 916 96.5 2.2 1.3 236.8 9.1 e
2 Microsemi 204 98.5 0.5 1.0 246.8 5.7 e
3 Sysmex KX21 446 98.9 0.0 1.1 234.1 4.0 e
4 Sysmex PocH - 100i 218 98.2 0.0 1.8 238.7 4.9 e
5 Sysmex XP 300 148 99.3 0.0 0.7 242.1 4.0 e
6 Mythic 244 95.9 2.9 1.2 217.9 11.0 e
7 Swelab 68 98.5 1.5 0.0 220.1 9.8 e
8 MS4 8 75.0 25.0 0.0 194.0 21.1 e*
9 Abacus Junior 12 100.0 0.0 0.0 267.7 7.1 e
10 Medonic 19 100.0 0.0 0.0 226.7 5.3 e
11 Nihon Kohden Celltac 34 97.1 2.9 0.0 243.9 9.0 e
12 Samsung HC10 42 100.0 0.0 0.0 231.1 8.2 e
100 125 150 175 200 225 250 275 300 325 350
Thrombocytes (G/l)
1
2
3
4
5
6
7
8
9
10
11
12
MQ 2015/1 Page 12/181
CRP
I1 CRP
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Afinion 1144 99.4 0.5 0.1 44.7 7.8 e
2 NycoCard SingleTest- 494 80.4 7.7 11.9 49.4 11.7 e
3 Abx Micros 152 93.5 3.9 2.6 45.1 9.3 e
4 ABX Micros CRP200 341 95.3 3.8 0.9 44.0 9.9 e
5 Quick Read go 73 98.6 0.0 1.4 48.0 7.2 e
6 Turbidimetry 40 100.0 0.0 0.0 44.5 7.1 e
7 Cobas 11 100.0 0.0 0.0 44.5 5.9 e
8 Fuji Dri-Chem 22 91.0 4.5 4.5 47.3 12.6 e*
9 Eurolyser 117 70.9 7.7 21.4 40.8 12.6 e
10 AQT 90 FLEX 6 100.0 0.0 0.0 50.5 9.9 e*
11 Spotchem D-Concept 7 100.0 0.0 0.0 46.9 2.9 e
12 Other methods 4 100.0 0.0 0.0 42.8 5.9 e*
20 25 30 35 40 45 50 55 60 65 70
CRP (mg/l)
1
2
3
4
5
6
7
8
9
10
11
12
MQ 2015/1 Page 13/181
CRP
I1 CRP
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 QuikRead (Vollblut) 192 94.8 2.1 3.1 76.0 6.5 e
50 55 60 65 70 75 80 85 90 95 100
CRP (mg/l)
1
MQ 2015/1 Page 14/181
CRP emi
I6 CRP emi
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Microsemi 200 96.5 3.0 0.5 45.0 9.1 e
30 33 36 39 42 45 48 51 54 57 60
CRP emi (mg/l)
1
MQ 2015/1 Page 15/181
IgG
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Turbidimetry 10 100.0 0.0 0.0 10.3 4.8 e
2 Nephelometry 7 100.0 0.0 0.0 10.8 6.4 e
7.0 7.7 8.4 9.1 9.8 10.5 11.2 11.9 12.6 13.3 14.0
IgG (g/l)
1
2
MQ 2015/1 Page 16/181
IgA
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Turbidimetry 11 100.0 0.0 0.0 1.9 3.4 e
2 Nephelometry 7 100.0 0.0 0.0 2.1 5.9 e
1.30 1.45 1.60 1.75 1.90 2.05 2.20 2.35 2.50 2.65 2.80
IgA (g/l)
1
2
MQ 2015/1 Page 17/181
IgM
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Turbidimetry 4 100.0 0.0 0.0 1.0 2.2 e
2 Nephelometry 7 100.0 0.0 0.0 1.1 7.4 e
3 Cobas Integra 800/40 6 100.0 0.0 0.0 1.0 2.4 e
0.70 0.77 0.84 0.91 0.98 1.05 1.12 1.19 1.26 1.33 1.40
IgM (g/l)
1
2
3
MQ 2015/1 Page 18/181
IgE
I2 Plasmaproteins
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 9 88.9 0.0 11.1 99 8.7 e*
70 76 82 88 94 100 106 112 118 124 130
IgE (kU/L)
1
MQ 2015/1 Page 19/181
Alpha-1-Antitrypsin
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Nephelometry 4 100.0 0.0 0.0 1.12 11.3 e*
0.80 0.87 0.94 1.01 1.08 1.15 1.22 1.29 1.36 1.43 1.50
Alpha-1-Antitrypsin (g/l)
1
MQ 2015/1 Page 20/181
Anti-Streptolysin-Antibodies
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 10 100.0 0.0 0.0 114 8.1 e
80 87 94 101 108 115 122 129 136 143 150
Anti-Streptolysin-Antibodies (kIU/l)
1
MQ 2015/1 Page 21/181
Complement C3
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 12 100.0 0.0 0.0 1.33 8.4 e
0.90 0.99 1.08 1.17 1.26 1.35 1.44 1.53 1.62 1.71 1.80
Complement C3 (g/l)
1
MQ 2015/1 Page 22/181
Complement C4
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 11 100.0 0.0 0.0 0.26 6.9 e
0.180 0.196 0.212 0.228 0.244 0.260 0.276 0.292 0.308 0.324 0.340
Complement C4 (g/l)
1
MQ 2015/1 Page 23/181
Haptoglobin
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 13 100.0 0.0 0.0 1.13 4.5 e
0.80 0.87 0.94 1.01 1.08 1.15 1.22 1.29 1.36 1.43 1.50
Haptoglobin (g/l)
1
MQ 2015/1 Page 24/181
Transferrin
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 14 100.0 0.0 0.0 2.12 3.2 e
1.50 1.62 1.74 1.86 1.98 2.10 2.22 2.34 2.46 2.58 2.70
Transferrin (g/l)
1
MQ 2015/1 Page 25/181
Präalbumin
I2 Plasmaproteins
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 8 100.0 0.0 0.0 177.0 3.8 e
120 131 142 153 164 175 186 197 208 219 230
Präalbumin (mg/l)
1
MQ 2015/1 Page 26/181
Albumine
K1 Clinical Chemistry
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 14 100.0 0.0 0.0 34 5.9 e*
2 Cobas 14 100.0 0.0 0.0 36 3.0 e
3 Fuji Dri-Chem 165 98.8 0.0 1.2 42 3.7 e
4 Spotchem/Ready 45 93.4 2.2 4.4 35 4.8 e
5 Spotchem D-Concept 64 95.3 1.6 3.1 44 5.7 e
6 Piccolo 27 100.0 0.0 0.0 38 2.5 e
7 Abx Mira 8 100.0 0.0 0.0 34 5.1 e*
8 Hitachi S40/M40 8 100.0 0.0 0.0 35 3.3 e
25 28 31 34 37 40 43 46 49 52 55
Albumine (g/l)
1
2
3
4
5
6
7
8
MQ 2015/1 Page 27/181
Alkaline phosphatase
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 IFCC/SGKC 37'C 9 88.9 11.1 0.0 172 7.3 e*
2 Cobas 19 100.0 0.0 0.0 161 5.4 e
3 Reflotron 707 97.4 0.8 1.8 179 6.0 e
4 Fuji Dri-Chem 640 98.3 0.3 1.4 169 4.7 e
5 Spotchem/Ready 127 92.9 5.5 1.6 188 8.4 e
6 Spotchem D-Concept 118 98.4 0.8 0.8 169 6.4 e
7 Hitachi S40/M40 12 100.0 0.0 0.0 137 5.2 e
8 Olympus 5 100.0 0.0 0.0 207 2.4 e
9 Piccolo 26 100.0 0.0 0.0 179 3.8 e
10 Abx Mira 21 95.2 0.0 4.8 171 6.2 e
100 116 132 148 164 180 196 212 228 244 260
Alkaline phosphatase (U/l)
1
2
3
4
5
6
7
8
9
10
MQ 2015/1 Page 28/181
Amylase
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 IFCC EPS liquid 37°C 10 100.0 0.0 0.0 162 5.9 e
2 Cobas 7 100.0 0.0 0.0 155 1.0 e
3 Reflotron 191 98.0 1.0 1.0 177 5.6 e
4 Fuji Dri-Chem 476 99.0 0.2 0.8 146 3.7 e
5 Spotchem/Ready 83 90.4 7.2 2.4 182 9.0 e
6 Spotchem D-Concept 88 100.0 0.0 0.0 188 5.6 e
7 Piccolo 25 100.0 0.0 0.0 138 2.2 e
8 Abx Mira 9 100.0 0.0 0.0 140 5.0 e
9 Hitachi S40/M40 7 100.0 0.0 0.0 175 5.4 e
100 115 130 145 160 175 190 205 220 235 250
Amylase (U/l)
1
2
3
4
5
6
7
8
9
MQ 2015/1 Page 29/181
Pancreatic amylase
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 IFCC EPS liquid 37°C 18 94.4 0.0 5.6 128 6.0 e
2 Cobas 13 100.0 0.0 0.0 128 5.1 e
3 Reflotron 462 98.0 0.9 1.1 149 5.9 e
100 110 120 130 140 150 160 170 180 190 200
Pancreatic amylase (U/l)
1
2
3
MQ 2015/1 Page 30/181
Bilirubin
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 12 100.0 0.0 0.0 60.7 4.7 e
2 Cobas 18 100.0 0.0 0.0 56.9 4.6 e
3 Reflotron 521 96.8 1.3 1.9 53.8 6.0 e
4 Fuji Dri-Chem 481 98.4 0.4 1.2 57.3 4.3 e
5 Spotchem/Ready 100 95.0 2.0 3.0 60.1 6.0 e
6 Spotchem D-Concept 95 96.8 0.0 3.2 47.0 4.0 e
7 Beckman/Olympus 5 100.0 0.0 0.0 65.2 2.7 e
8 Piccolo 24 95.8 4.2 0.0 59.9 6.4 e
9 Abx Mira 20 95.0 0.0 5.0 61.5 6.5 e
10 Hitachi S40/M40 11 100.0 0.0 0.0 65.9 4.1 e
30 35 40 45 50 55 60 65 70 75 80
Bilirubin (µmol/l)
1
2
3
4
5
6
7
8
9
10
MQ 2015/1 Page 31/181
Bilirubin direct
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Fuji Dri-Chem 30 96.7 0.0 3.3 33.2 5.3 e
25.0 26.5 28.0 29.5 31.0 32.5 34.0 35.5 37.0 38.5 40.0
Bilirubin direct (µmol/l)
1
MQ 2015/1 Page 32/181
Calcium
K1 Clinical Chemistry
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 17 100.0 0.0 0.0 2.51 2.2 e
2 Cobas 13 100.0 0.0 0.0 2.56 2.0 e
3 Fuji Dri-Chem 341 98.2 0.0 1.8 2.63 4.1 e
4 Spotchem/Ready 49 96.0 2.0 2.0 2.41 5.2 e
5 Spotchem D-Concept 62 88.7 9.7 1.6 2.07 7.1 e
6 Piccolo 25 100.0 0.0 0.0 2.51 1.6 e
7 Abx Mira 14 100.0 0.0 0.0 2.49 3.0 e
8 Hitachi S40/M40 9 100.0 0.0 0.0 2.48 5.3 e*
1.50 1.66 1.82 1.98 2.14 2.30 2.46 2.62 2.78 2.94 3.10
Calcium (mmol/l)
1
2
3
4
5
6
7
8
MQ 2015/1 Page 33/181
Chloride
K1 Clinical Chemistry
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ISE 14 92.9 7.1 0.0 99 2.9 e*
2 Cobas 11 100.0 0.0 0.0 96 2.6 e*
3 Fuji Dri-Chem 560 95.9 2.1 2.0 104 2.4 e
4 Spotchem D-Concept 107 92.5 1.9 5.6 107 2.4 e
5 Spotchem EL-SE 1520 116 93.2 3.4 3.4 111 3.1 e
6 Piccolo 16 93.7 0.0 6.3 97 2.8 e
7 iStat Chem8 4 100.0 0.0 0.0 103 1.3 e
85 89 93 97 101 105 109 113 117 121 125
Chloride (mmol/l)
1
2
3
4
5
6
7
MQ 2015/1 Page 34/181
Cholesterol total
K1 Clinical Chemistry
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 18 100.0 0.0 0.0 4.9 3.8 e
2 Cobas 17 100.0 0.0 0.0 4.8 3.8 e
3 Reflotron 831 97.2 2.0 0.8 4.6 4.1 e
4 Fuji Dri-Chem 662 99.0 0.5 0.5 4.8 3.3 e
5 Spotchem/Ready 151 92.8 4.6 2.6 4.8 4.7 e
6 Spotchem D-Concept 122 95.9 3.3 0.8 4.7 4.1 e
7 Piccolo 22 100.0 0.0 0.0 4.9 1.5 e
8 Cholestech LDX 191 95.9 3.1 1.0 4.7 4.5 e
9 Abx Mira 21 95.2 4.8 0.0 4.8 3.7 e
10 Hitachi S40/M40 12 100.0 0.0 0.0 4.8 2.3 e
3.90 4.07 4.24 4.41 4.58 4.75 4.92 5.09 5.26 5.43 5.60
Cholesterol total (mmol/l)
1
2
3
4
5
6
7
8
9
10
MQ 2015/1 Page 35/181
Cholesterin HDL
K1 Clinical Chemistry
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Wet chemistry, direc 16 93.7 0.0 6.3 1.28 5.5 e
2 Cobas 15 100.0 0.0 0.0 1.05 5.3 e
3 Reflotron 626 93.4 3.7 2.9 1.13 9.7 e
4 Fuji Dri-Chem 622 99.1 0.3 0.6 1.32 3.7 e
5 Spotchem/Ready 137 94.1 1.5 4.4 0.94 8.0 e
6 Spotchem D-Concept 121 93.4 4.1 2.5 1.01 10.1 e
7 Piccolo 22 100.0 0.0 0.0 1.19 7.0 e
8 Cholestech LDX 191 95.3 2.1 2.6 1.29 7.8 e
9 Abx Mira 20 100.0 0.0 0.0 1.28 5.4 e
10 Hitachi S40/M40 11 81.8 9.1 9.1 1.32 8.7 e*
0.50 0.63 0.76 0.89 1.02 1.15 1.28 1.41 1.54 1.67 1.80
Cholesterin HDL (mmol/l)
1
2
3
4
5
6
7
8
9
10
MQ 2015/1 Page 36/181
Creatine kinase
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 IFCC/SGKC 37'C 17 100.0 0.0 0.0 311 5.0 e
2 Cobas 16 100.0 0.0 0.0 325 4.1 e
3 Reflotron 430 94.1 4.0 1.9 293 8.7 e
4 Fuji Dri-Chem 410 99.5 0.5 0.0 327 4.0 e
5 Spotchem/Ready 59 84.7 6.8 8.5 275 9.8 e
6 Spotchem D-Concept 74 97.2 1.4 1.4 316 6.3 e
7 Piccolo 7 100.0 0.0 0.0 335 2.9 e
8 Abx Mira 17 94.1 5.9 0.0 307 5.6 e
9 Hitachi S40/M40 6 100.0 0.0 0.0 272 5.1 e
200 221 242 263 284 305 326 347 368 389 410
Creatine kinase (U/l)
1
2
3
4
5
6
7
8
9
MQ 2015/1 Page 37/181
Iron
K1 Clinical Chemistry
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 8 100.0 0.0 0.0 28 6.1 e
2 Cobas 11 100.0 0.0 0.0 28 2.3 e
3 Abx Mira 6 100.0 0.0 0.0 27 4.0 e
20.0 21.5 23.0 24.5 26.0 27.5 29.0 30.5 32.0 33.5 35.0
Iron (µmol/l)
1
2
3
MQ 2015/1 Page 38/181
Gamma-glutamyltransferase
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 IFCC/SGKC 37'C 6 100.0 0.0 0.0 81 4.1 e
2 Cobas 17 100.0 0.0 0.0 82 6.4 e
3 Reflotron 919 98.5 1.2 0.3 109 6.1 e
4 Fuji Dri-Chem 695 99.3 0.3 0.4 110 4.6 e
5 Spotchem/Ready 155 96.8 1.9 1.3 95 7.7 e
6 Spotchem D-Concept 134 97.8 1.5 0.7 100 7.0 e
7 DGKC 37'C 10 100.0 0.0 0.0 84 7.1 e*
8 Piccolo 28 100.0 0.0 0.0 76 4.1 e
9 Abx Mira 22 95.5 4.5 0.0 83 5.3 e
10 Hitachi S40/M40 14 92.9 0.0 7.1 93 2.7 e
50 60 70 80 90 100 110 120 130 140 150
Gamma-glutamyltransferase (U/l)
1
2
3
4
5
6
7
8
9
10
MQ 2015/1 Page 39/181
Glucose
K1 Clinical Chemistry
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 25 92.0 4.0 4.0 9.5 4.9 e
2 Cobas 18 100.0 0.0 0.0 9.8 2.9 e
3 Reflotron 941 93.7 3.6 2.7 9.5 4.8 e
4 Fuji Dri-Chem 656 99.2 0.6 0.2 9.0 2.1 e
5 Spotchem/Ready 141 92.2 3.5 4.3 9.8 4.4 e
6 Spotchem D-Concept 125 99.2 0.0 0.8 9.4 4.2 e
7 Piccolo 31 100.0 0.0 0.0 9.6 2.0 e
8 Cholestech LDX 155 84.5 10.3 5.2 9.0 5.9 e
9 Abx Mira 22 100.0 0.0 0.0 9.6 4.0 e
10 Lange 5 100.0 0.0 0.0 8.8 3.1 e*
11 Hitachi S40/M40 15 86.7 13.3 0.0 9.7 5.3 e*
12 iStat Chem8 4 100.0 0.0 0.0 9.0 1.3 e
7.0 7.4 7.8 8.2 8.6 9.0 9.4 9.8 10.2 10.6 11.0
Glucose (mmol/l)
1
2
3
4
5
6
7
8
9
10
11
12
MQ 2015/1 Page 40/181
Glucose
K1 Clinical Chemistry
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Accu-Chek Aviva 380 98.9 0.3 0.8 10.1 3.1 e
2 Accu-Chek Inform 2 229 97.8 1.3 0.9 10.1 3.5 e
3 Accu-Chek Mobile 5 100.0 0.0 0.0 11.1 5.9 e*
4 Bayer Contour 2 (5s) 66 92.5 3.0 4.5 7.7 4.4 e
5 Bayer Contour XT/NEX 1103 95.6 3.0 1.4 10.2 4.3 e
6 Bayer Breeze 2 19 94.7 5.3 0.0 16.2 5.5 e*
7 Glucocard 10 90.0 0.0 10.0 14.7 4.3 e*
8 Omnitest 11 90.9 9.1 0.0 17.3 5.1 e*
9 Hemocue 201+ P-equiv 79 97.4 1.3 1.3 10.9 4.0 e
10 Hemocue 201RT P-equi 33 90.9 3.0 6.1 10.8 2.8 e
11 Freestyle precision/ 4 75.0 25.0 0.0 10.4 6.0 e*
12 Freestyle Freedom li 11 100.0 0.0 0.0 10.6 5.0 e*
6.0 7.5 9.0 10.5 12.0 13.5 15.0 16.5 18.0 19.5 21.0
Glucose (mmol/l)
1
2
3
4
5
6
7
8
9
10
11
12
MQ 2015/1 Page 41/181
Glucose B
K1 Clinical Chemistry
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Bayer Elite 10 80.0 10.0 10.0 10.9 6.2 e*
2 Hemocue 201+ (alt) 59 98.3 1.7 0.0 10.4 4.7 e
3 mylife Pura 53 100.0 0.0 0.0 11.5 2.4 e
4 AccuChek Sensor 7 100.0 0.0 0.0 10.2 3.4 e*
5 OneTouch Ultra 25 76.0 0.0 24.0 13.5 4.0 e
6 OneTouch Verio 4 100.0 0.0 0.0 9.7 1.9 e
7 AccuChek Compact 6 100.0 0.0 0.0 10.5 3.0 e*
8 Bayer Contour (15s) 89 88.8 5.6 5.6 12.5 5.0 e
9 Healthpro 15 100.0 0.0 0.0 16.3 4.3 e
10 Sanofi BG Star 7 100.0 0.0 0.0 13.5 2.2 e
11 Mylife UNIO 4 75.0 0.0 25.0 10.7 0.5 e
8.0 9.1 10.2 11.3 12.4 13.5 14.6 15.7 16.8 17.9 19.0
Glucose B (mmol/l)
1
2
3
4
5
6
7
8
9
10
11
MQ 2015/1 Page 42/181
Uric Acid
K1 Clinical Chemistry
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 18 94.4 0.0 5.6 382 4.1 e
2 Cobas 14 100.0 0.0 0.0 375 2.5 e
3 Reflotron 817 97.2 1.2 1.6 402 4.2 e
4 Fuji Dri-Chem 655 99.5 0.0 0.5 408 2.1 e
5 Spotchem/Ready 129 94.6 2.3 3.1 354 4.8 e
6 Spotchem D-Concept 119 100.0 0.0 0.0 376 4.0 e
7 Piccolo 23 95.7 4.3 0.0 319 6.1 e
8 Abx Mira 20 100.0 0.0 0.0 364 3.6 e
9 Hitachi S40/M40 13 92.3 0.0 7.7 378 3.2 e
250 275 300 325 350 375 400 425 450 475 500
Uric Acid (µmol/l)
1
2
3
4
5
6
7
8
9
MQ 2015/1 Page 43/181
Urea
K1 Clinical Chemistry
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 16 100.0 0.0 0.0 15.3 4.2 e
2 Cobas 17 100.0 0.0 0.0 14.9 4.0 e
3 Reflotron 357 96.6 1.7 1.7 15.7 6.3 e
4 Fuji Dri-Chem 411 99.0 0.0 1.0 15.4 2.2 e
5 Spotchem/Ready 89 79.8 10.1 10.1 13.4 8.8 e
6 Spotchem D-Concept 77 80.5 10.4 9.1 14.5 9.3 e
7 Piccolo 29 100.0 0.0 0.0 14.8 2.8 e
8 Abx Mira 11 100.0 0.0 0.0 14.9 4.4 e
9 Hitachi S40/M40 9 88.9 0.0 11.1 14.5 2.7 e
10 iStat Chem8 6 83.3 0.0 16.7 18.6 2.9 e
9.0 10.5 12.0 13.5 15.0 16.5 18.0 19.5 21.0 22.5 24.0
Urea (mmol/l)
1
2
3
4
5
6
7
8
9
10
MQ 2015/1 Page 44/181
Potassium
K1 Clinical Chemistry
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ISE 26 96.2 0.0 3.8 4.60 1.8 e
2 Cobas 18 100.0 0.0 0.0 4.67 1.9 e
3 Reflotron 850 92.7 5.3 2.0 4.87 3.1 e
4 Fuji Dri-Chem 689 95.2 3.2 1.6 4.59 2.2 e
5 Spotchem D-Concept 120 97.5 0.8 1.7 4.40 1.9 e
6 Spotchem EL-SE 1520 121 92.5 5.8 1.7 4.34 2.9 e
7 Piccolo 17 70.6 17.6 11.8 4.76 4.5 e*
8 Abx Mira 7 71.4 14.3 14.3 4.53 3.3 e*
9 iStat Chem8 5 100.0 0.0 0.0 4.50 1.2 e
3.90 4.05 4.20 4.35 4.50 4.65 4.80 4.95 5.10 5.25 5.40
Potassium (mmol/l)
1
2
3
4
5
6
7
8
9
MQ 2015/1 Page 45/181
Creatinine
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 7 100.0 0.0 0.0 259 1.5 e
2 Cobas 19 100.0 0.0 0.0 246 4.5 e
3 Reflotron 1025 98.2 0.7 1.1 297 5.8 e
4 Fuji Dri-Chem 725 98.5 0.7 0.8 251 4.9 e
5 Jaffé 8 100.0 0.0 0.0 256 5.0 e
6 Enzymatic 4 100.0 0.0 0.0 258 1.6 e
7 Piccolo 29 100.0 0.0 0.0 250 5.0 e
8 Abx Mira 22 100.0 0.0 0.0 253 5.9 e
9 Hitachi S40/M40 14 92.9 0.0 7.1 253 2.8 e
150 175 200 225 250 275 300 325 350 375 400
Creatinine (µmol/l)
1
2
3
4
5
6
7
8
9
MQ 2015/1 Page 46/181
Creatinine E
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Statsensor i / Nova 26 92.3 7.7 0.0 462 11.7 e*
2 iStat Chem8 7 100.0 0.0 0.0 279 1.3 e
3 ABL700/800 Radiomete 10 100.0 0.0 0.0 272 3.2 e
200 240 280 320 360 400 440 480 520 560 600
Creatinine E (µmol/l)
1
2
3
MQ 2015/1 Page 47/181
eGFR
K1 Clinical Chemistry
QUALAB tolerance : 30 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 CKD-EPI 739 95.6 1.4 3.0 29 12.7 a
2 Cockcroft-Gault 46 89.2 6.5 4.3 33 16.7 a
3 MDRD 19 79.0 10.5 10.5 28 21.0 a
10 14 18 22 26 30 34 38 42 46 50
eGFR ()
1
2
3
MQ 2015/1 Page 48/181
LDH
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 IFCC 18 100.0 0.0 0.0 222 5.2 e
2 Cobas 9 100.0 0.0 0.0 450 1.1 e
3 Fuji Dri-Chem 143 97.2 0.7 2.1 193 5.1 e
4 Spotchem/Ready 36 91.7 0.0 8.3 170 7.0 e
5 Spotchem D-Concept 35 94.3 5.7 0.0 172 10.5 e
6 Abx Mira 12 100.0 0.0 0.0 221 7.4 e
100 150 200 250 300 350 400 450 500 550 600
LDH (U/l)
1
2
3
4
5
6
MQ 2015/1 Page 49/181
Magnesium
K1 Clinical Chemistry
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 13 92.3 0.0 7.7 1.08 4.1 e
2 Cobas 12 100.0 0.0 0.0 1.10 2.8 e
3 Fuji Dri-Chem 111 98.2 0.0 1.8 1.14 4.3 e
4 Spotchem D-Concept 22 100.0 0.0 0.0 0.90 5.5 e
5 Spotchem/Ready 16 100.0 0.0 0.0 0.92 4.1 e
6 Piccolo 4 100.0 0.0 0.0 1.08 2.7 e
0.70 0.77 0.84 0.91 0.98 1.05 1.12 1.19 1.26 1.33 1.40
Magnesium (mmol/l)
1
2
3
4
5
6
MQ 2015/1 Page 50/181
Sodium
K1 Clinical Chemistry
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ISE 25 92.0 0.0 8.0 144 1.8 e
2 Cobas 17 100.0 0.0 0.0 143 1.4 e
3 Fuji Dri-Chem 640 97.2 1.7 1.1 145 1.8 e
4 Spotchem D-Concept 116 98.3 1.7 0.0 139 1.7 e
5 Spotchem EL-SE 1520 121 97.5 0.8 1.7 139 2.1 e
6 Piccolo 18 100.0 0.0 0.0 140 1.7 e
7 Abx Mira 8 100.0 0.0 0.0 146 2.4 e*
8 iStat Chem8 5 100.0 0.0 0.0 143 0.3 e
125.0 128.5 132.0 135.5 139.0 142.5 146.0 149.5 153.0 156.5 160.0
Sodium (mmol/l)
1
2
3
4
5
6
7
8
MQ 2015/1 Page 51/181
Phosphate
K1 Clinical Chemistry
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 11 100.0 0.0 0.0 1.5 3.3 e
2 Cobas 12 100.0 0.0 0.0 1.5 4.3 e
3 Fuji Dri-Chem 72 98.6 1.4 0.0 1.6 3.5 e
4 Spotchem D-Concept 15 100.0 0.0 0.0 1.7 5.1 e
5 Spotchem/Ready 6 100.0 0.0 0.0 1.4 2.8 e
6 Piccolo 7 100.0 0.0 0.0 1.8 2.7 e
7 Abx Mira 5 100.0 0.0 0.0 1.6 3.7 e
1.00 1.12 1.24 1.36 1.48 1.60 1.72 1.84 1.96 2.08 2.20
Phosphate (mmol/l)
1
2
3
4
5
6
7
MQ 2015/1 Page 52/181
Protein total
K1 Clinical Chemistry
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 15 100.0 0.0 0.0 56.0 3.3 e
2 Cobas 13 100.0 0.0 0.0 54.7 2.1 e
3 Fuji Dri-Chem 175 98.9 0.0 1.1 52.9 2.6 e
4 Spotchem/Ready 40 90.0 10.0 0.0 55.8 7.5 e
5 Spotchem D-Concept 57 82.4 8.8 8.8 58.3 6.6 e
6 Piccolo 22 100.0 0.0 0.0 57.3 1.7 e
7 Abx Mira 8 100.0 0.0 0.0 58.3 3.4 e
8 Hitachi S40/M40 5 100.0 0.0 0.0 58.0 4.2 e*
45.0 47.5 50.0 52.5 55.0 57.5 60.0 62.5 65.0 67.5 70.0
Protein total (g/l)
1
2
3
4
5
6
7
8
MQ 2015/1 Page 53/181
Aspartate aminotransferase
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 IFCC with Pyridox 37 14 100.0 0.0 0.0 134 3.6 e
2 Cobas 18 94.4 0.0 5.6 129 3.6 e
3 Reflotron 933 97.2 1.4 1.4 167 6.6 e
4 Fuji Dri-Chem 693 99.7 0.0 0.3 127 2.8 e
5 Spotchem/Ready 163 97.0 1.8 1.2 117 5.8 e
6 Spotchem D-Concept 128 100.0 0.0 0.0 130 5.4 e
7 IFCC with Pyridox 37 5 100.0 0.0 0.0 134 1.5 e
8 Piccolo 29 100.0 0.0 0.0 126 2.9 e
9 Abx Mira 22 100.0 0.0 0.0 131 5.7 e
10 Hitachi S40/M40 16 87.5 0.0 12.5 134 2.2 e
90 105 120 135 150 165 180 195 210 225 240
Aspartate aminotransferase (U/l)
1
2
3
4
5
6
7
8
9
10
MQ 2015/1 Page 54/181
Alanine aminotransferase
K1 Clinical Chemistry
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 IFCC with Pyridox 37 15 100.0 0.0 0.0 98 4.0 e
2 Cobas 19 94.7 0.0 5.3 93 3.1 e
3 Reflotron 964 98.1 1.0 0.9 90 5.0 e
4 Fuji Dri-Chem 711 98.7 0.7 0.6 92 4.1 e
5 Spotchem/Ready 165 96.4 1.2 2.4 76 5.8 e
6 Spotchem D-Concept 133 98.4 0.8 0.8 68 6.1 e
7 Piccolo 30 96.7 0.0 3.3 85 3.1 e
8 Abx Mira 22 95.5 4.5 0.0 94 7.0 e
9 Hitachi S40/M40 15 86.7 0.0 13.3 97 3.5 e
40 48 56 64 72 80 88 96 104 112 120
Alanine aminotransferase (U/l)
1
2
3
4
5
6
7
8
9
MQ 2015/1 Page 55/181
Triglycerides
K1 Clinical Chemistry
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 20 100.0 0.0 0.0 1.73 6.3 e
2 Cobas 18 100.0 0.0 0.0 1.66 4.8 e
3 Reflotron 725 95.6 2.5 1.9 1.74 7.9 e
4 Fuji Dri-Chem 643 99.0 0.2 0.8 1.73 3.3 e
5 Spotchem/Ready 144 99.3 0.0 0.7 1.54 4.8 e
6 Spotchem D-Concept 121 98.3 0.0 1.7 1.71 4.6 e
7 Hitachi S40/M40 11 81.8 0.0 18.2 1.64 3.7 e
8 Piccolo 20 100.0 0.0 0.0 1.88 3.0 e
9 Cholestech LDX 191 99.0 0.0 1.0 1.73 5.5 e
10 Abx Mira 20 100.0 0.0 0.0 1.66 3.6 e
1.00 1.15 1.30 1.45 1.60 1.75 1.90 2.05 2.20 2.35 2.50
Triglycerides (mmol/l)
1
2
3
4
5
6
7
8
9
10
MQ 2015/1 Page 56/181
Fructosamine
K1 Clinical Chemistry
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Spotchem/Ready 4 100.0 0.0 0.0 237 7.5 e*
190 199 208 217 226 235 244 253 262 271 280
Fructosamine (µmol/l)
1
MQ 2015/1 Page 57/181
Bicarbonat
K1 Clinical Chemistry
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Piccolo 6 100.0 0.0 0.0 22 4.7 e*
18.0 18.8 19.6 20.4 21.2 22.0 22.8 23.6 24.4 25.2 26.0
Bicarbonat (mmol/l)
1
MQ 2015/1 Page 58/181
LDL Cholesterin
K1 Clinical Chemistry
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Abx Mira 10 100.0 0.0 0.0 2.7 6.0 e
2 Standard chemistry 7 100.0 0.0 0.0 2.9 10.1 e*
3 Roche, Cobas 5 100.0 0.0 0.0 3.0 1.4 e
4 Hitachi S40/M40 5 80.0 0.0 20.0 2.5 3.9 e
1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00
LDL Cholesterin (mmol/l)
1
2
3
4
MQ 2015/1 Page 59/181
Lithium
K1 Clinical Chemistry
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 14 100.0 0.0 0.0 1.17 5.3 e
0.90 0.95 1.00 1.05 1.10 1.15 1.20 1.25 1.30 1.35 1.40
Lithium (mmol/l)
1
MQ 2015/1 Page 60/181
Lactate
K1 Clinical Chemistry
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 7 100.0 0.0 0.0 3.67 4.6 e
3.00 3.15 3.30 3.45 3.60 3.75 3.90 4.05 4.20 4.35 4.50
Lactate (mmol/l)
1
MQ 2015/1 Page 61/181
Lipase
K34 Lipase
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Abx Mira 6 83.3 16.7 0.0 41.5 11.2 e*
2 Architect 4 100.0 0.0 0.0 46.0 2.5 e
3 Beckman/Olympus 4 100.0 0.0 0.0 47.0 4.8 e*
4 Standard chemistry 8 100.0 0.0 0.0 44.3 4.8 e
5 Fuji Dri-Chem 47 95.7 0.0 4.3 57.4 3.7 e
30 34 38 42 46 50 54 58 62 66 70
Lipase (U/l)
1
2
3
4
5
MQ 2015/1 Page 62/181
Creatinine SP
K13 Creatinine Spotchem
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Spotchem/Ready 159 84.9 10.7 4.4 92 11.3 e
2 Spotchem D-Concept 130 93.1 4.6 2.3 81 8.3 e
60 66 72 78 84 90 96 102 108 114 120
Creatinine SP (µmol/l)
1
2
MQ 2015/1 Page 63/181
eGFR (Spotchem)
K13 Creatinine Spotchem
QUALAB tolerance : 30 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 CKD-EPI 91 91.2 0.0 8.8 119 11.0 a
2 Cockcroft-Gault 6 83.3 0.0 16.7 129 15.5 a
3 MDRD 4 75.0 0.0 25.0 108 16.6 a
70 81 92 103 114 125 136 147 158 169 180
eGFR (Spotchem) ()
1
2
3
MQ 2015/1 Page 64/181
HbA1c sample A
K3 HbA1c
QUALAB tolerance : 9 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b101 25 100.0 0.0 0.0 5.5 2.4 e
2 Afinion 610 99.5 0.2 0.3 5.7 2.8 e
3 Eurolyser 12 100.0 0.0 0.0 5.5 3.8 e*
4 Hemocue HbA1c 501 10 70.0 20.0 10.0 5.6 6.9 e*
5 NycoCard 108 86.1 6.5 7.4 5.8 5.5 e
6 DCA2000/Vantage 224 99.2 0.4 0.4 5.5 2.8 e
7 Others 10 100.0 0.0 0.0 5.6 4.0 e*
8 HPLC 6 83.3 16.7 0.0 5.6 5.4 e*
9 Roche, Cobas 20 90.0 5.0 5.0 5.6 4.3 e
4.50 4.75 5.00 5.25 5.50 5.75 6.00 6.25 6.50 6.75 7.00
HbA1c sample A (%)
1
2
3
4
5
6
7
8
9
MQ 2015/1 Page 65/181
HbA1c sample B
K3 HbA1c
QUALAB tolerance : 9 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b101 21 100.0 0.0 0.0 5.8 2.9 e
2 Afinion 556 98.9 0.7 0.4 5.9 2.9 e
3 Eurolyser 10 100.0 0.0 0.0 5.7 3.5 e*
4 A1c Now 5 80.0 20.0 0.0 5.9 7.6 e*
5 Hemocue HbA1c 501 11 81.8 0.0 18.2 5.9 4.8 e*
6 NycoCard 116 76.8 10.3 12.9 5.9 5.5 e
7 DCA2000/Vantage 192 98.5 0.5 1.0 5.7 2.9 e
8 Others 7 100.0 0.0 0.0 5.6 4.1 e*
9 Roche, Cobas 15 100.0 0.0 0.0 5.7 3.3 e
5.0 5.2 5.4 5.6 5.8 6.0 6.2 6.4 6.6 6.8 7.0
HbA1c sample B (%)
1
2
3
4
5
6
7
8
9
MQ 2015/1 Page 66/181
pCO2
K4 Blood gases
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b121/123/221 17 100.0 0.0 0.0 5.77 3.2 e
2 iStat 37 100.0 0.0 0.0 4.98 3.4 e
3 EPOC 22 81.8 9.1 9.1 5.04 7.4 e
4.0 4.3 4.6 4.9 5.2 5.5 5.8 6.1 6.4 6.7 7.0
pCO2 (kPa)
1
2
3
MQ 2015/1 Page 67/181
pO2
K4 Blood gases
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b121/123/221 14 100.0 0.0 0.0 15.49 5.5 e
2 iStat 36 86.1 11.1 2.8 15.07 7.8 e
3 EPOC 22 81.9 4.5 13.6 14.20 7.2 e
11.0 11.8 12.6 13.4 14.2 15.0 15.8 16.6 17.4 18.2 19.0
pO2 (kPa)
1
2
3
MQ 2015/1 Page 68/181
pH
K4 Blood gases
QUALAB tolerance : 1 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b121/123/221 16 100.0 0.0 0.0 7.40 0.2 e
2 iStat 37 100.0 0.0 0.0 7.43 0.1 e
3 EPOC 22 95.5 4.5 0.0 7.39 0.3 e
7.300 7.321 7.342 7.363 7.384 7.405 7.426 7.447 7.468 7.489 7.510
pH ()
1
2
3
MQ 2015/1 Page 69/181
Glucose BG
K4 Blood gases
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b121/123/221 5 60.0 40.0 0.0 5.6 9.5 e*
2 iStat 13 100.0 0.0 0.0 5.4 1.8 e
3 EPOC 16 100.0 0.0 0.0 5.6 2.8 e
4.5 4.7 4.9 5.1 5.3 5.5 5.7 5.9 6.1 6.3 6.5
Glucose BG (mmol/l)
1
2
3
MQ 2015/1 Page 70/181
Potassium BG
K4 Blood gases
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b121/123/221 15 100.0 0.0 0.0 3.8 1.0 e
2 iStat 20 100.0 0.0 0.0 3.8 1.3 e
3 EPOC 20 100.0 0.0 0.0 3.7 1.4 e
3.40 3.47 3.54 3.61 3.68 3.75 3.82 3.89 3.96 4.03 4.10
Potassium BG (mmol/l)
1
2
3
MQ 2015/1 Page 71/181
Sodium BG
K4 Blood gases
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b121/123/221 16 100.0 0.0 0.0 139.6 1.9 e
2 iStat 20 100.0 0.0 0.0 143.8 0.5 e
3 EPOC 19 100.0 0.0 0.0 138.2 1.0 e
125 128 131 134 137 140 143 146 149 152 155
Sodium BG (mmol/l)
1
2
3
MQ 2015/1 Page 72/181
Chlorid-BG
K4 Blood gases
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b121/123/221 6 100.0 0.0 0.0 97.1 2.4 e*
90.0 91.5 93.0 94.5 96.0 97.5 99.0 100.5 102.0 103.5 105.0
Chlorid-BG (mmol/l)
1
MQ 2015/1 Page 73/181
Calcium-BG
K4 Blood gases
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b121/123/221 11 90.9 0.0 9.1 0.51 6.7 e*
2 iStat 12 100.0 0.0 0.0 0.47 1.1 e
3 EPOC 20 95.0 0.0 5.0 0.47 3.0 e
0.40 0.42 0.44 0.46 0.48 0.50 0.52 0.54 0.56 0.58 0.60
Calcium-BG (mmol/l)
1
2
3
MQ 2015/1 Page 74/181
Lactate-BG
K4 Blood gases
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b121/123/221 5 60.0 40.0 0.0 1.90 6.8 e*
2 EPOC 20 95.0 5.0 0.0 1.62 4.9 e
3 iStat 7 100.0 0.0 0.0 1.63 2.2 e
1.40 1.48 1.56 1.64 1.72 1.80 1.88 1.96 2.04 2.12 2.20
Lactate-BG (mmol/l)
1
2
3
MQ 2015/1 Page 75/181
Calcium - Urine
U1 Urine quant.
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 13 100.0 0.0 0.0 2.11 2.5 e
1.80 1.86 1.92 1.98 2.04 2.10 2.16 2.22 2.28 2.34 2.40
Calcium - Urine (mmol/l)
1
MQ 2015/1 Page 76/181
Chloride - Urine
U1 Urine quant.
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 4 100.0 0.0 0.0 127 1.5 e*
2 ISE 5 100.0 0.0 0.0 138 1.9 a
115.0 118.5 122.0 125.5 129.0 132.5 136.0 139.5 143.0 146.5 150.0
Chloride - Urine (mmol/l)
1
2
MQ 2015/1 Page 77/181
Glucose - Urine
U1 Urine quant.
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 12 100.0 0.0 0.0 6.6 3.0 e
5.80 5.96 6.12 6.28 6.44 6.60 6.76 6.92 7.08 7.24 7.40
Glucose - Urine (mmol/l)
1
MQ 2015/1 Page 78/181
Magnesium - Urine
U1 Urine quant.
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 8 100.0 0.0 0.0 2.9 4.6 e*
2.50 2.59 2.68 2.77 2.86 2.95 3.04 3.13 3.22 3.31 3.40
Magnesium - Urine (mmol/l)
1
MQ 2015/1 Page 79/181
Osmolality - Urine
U1 Urine quant.
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cryoskopy 6 100.0 0.0 0.0 565 0.3 e
500 515 530 545 560 575 590 605 620 635 650
Osmolality - Urine (mosm/kg)
1
MQ 2015/1 Page 80/181
Phosphate - Urine
U1 Urine quant.
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 14 100.0 0.0 0.0 10.8 4.3 e
8.50 8.95 9.40 9.85 10.30 10.75 11.20 11.65 12.10 12.55 13.00
Phosphate - Urine (mmol/l)
1
MQ 2015/1 Page 81/181
Potassium - Urine
U1 Urine quant.
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 18 100.0 0.0 0.0 45 3.2 e
35 37 39 41 43 45 47 49 51 53 55
Potassium - Urine (mmol/l)
1
MQ 2015/1 Page 82/181
total Protein - Urine
U1 Urine quant.
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas/Roche 12 100.0 0.0 0.0 286.6 6.2 e
2 Other methods 4 100.0 0.0 0.0 347.5 11.1 e*
200 225 250 275 300 325 350 375 400 425 450
total Protein - Urine (mg/l)
1
2
MQ 2015/1 Page 83/181
Sodium - Urine
U1 Urine quant.
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 17 100.0 0.0 0.0 110 1.8 e
90 94 98 102 106 110 114 118 122 126 130
Sodium - Urine (mmol/l)
1
MQ 2015/1 Page 84/181
Urea - Urine
U1 Urine quant.
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 14 100.0 0.0 0.0 189 4.9 e
150 158 166 174 182 190 198 206 214 222 230
Urea - Urine (mmol/l)
1
MQ 2015/1 Page 85/181
Uric Acid - Urine
U1 Urine quant.
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Standard chemistry 13 100.0 0.0 0.0 0.79 5.8 e
0.65 0.68 0.71 0.74 0.77 0.80 0.83 0.86 0.89 0.92 0.95
Uric Acid - Urine (mmol/l)
1
MQ 2015/1 Page 86/181
Specific Gravity - Urine
U1 Urine quant.
QUALAB tolerance : 5 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Refractometer 6 100.0 0.0 0.0 1.017 0.2 a
0.950 0.963 0.976 0.989 1.002 1.015 1.028 1.041 1.054 1.067 1.080
Specific Gravity - Urine ()
1
MQ 2015/1 Page 87/181
INR
G1 Coagulation INR
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Thromborel S 4 75.0 25.0 0.0 1.62 12.4 e*
2 Neoplastin Plus 5 100.0 0.0 0.0 2.01 4.2 e*
3 Innovin 16 93.7 0.0 6.3 1.63 2.8 e
4 Recombiplastin IL 5 100.0 0.0 0.0 1.68 4.5 e*
5 Other methods 5 80.0 20.0 0.0 1.70 11.0 e*
6 Neoplastin R 9 100.0 0.0 0.0 1.70 5.5 e*
1.30 1.41 1.52 1.63 1.74 1.85 1.96 2.07 2.18 2.29 2.40
INR ()
1
2
3
4
5
6
MQ 2015/1 Page 88/181
Fibrinogen OA
G1 Coagulation INR
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Other methods 11 90.9 9.1 0.0 0.99 10.2 e*
2 Siemens Thrombin 4 100.0 0.0 0.0 1.01 8.2 e*
3 Stago/STA 7 100.0 0.0 0.0 1.10 4.9 e*
0.80 0.85 0.90 0.95 1.00 1.05 1.10 1.15 1.20 1.25 1.30
Fibrinogen OA (g/l)
1
2
3
MQ 2015/1 Page 89/181
Activated Prothrombin Time
G1 Coagulation INR
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Other methods 15 100.0 0.0 0.0 44.1 9.5 e
2 Actin FS 8 75.0 25.0 0.0 42.8 14.6 e*
3 Stago/STA 6 100.0 0.0 0.0 49.6 4.0 e
30 34 38 42 46 50 54 58 62 66 70
Activated Prothrombin Time (Sek)
1
2
3
MQ 2015/1 Page 90/181
Prothrombin time NT
G3 Coagulation NT
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Neoplastin R 6 100.0 0.0 0.0 96 1.1 e
2 Innovin 9 100.0 0.0 0.0 96 5.3 e
3 all Participants 5 100.0 0.0 0.0 100 4.2 e*
4 Recombiplastin IL 6 100.0 0.0 0.0 100 0.0 e
75 80 85 90 95 100 105 110 115 120 125
Prothrombin time NT (%)
1
2
3
4
MQ 2015/1 Page 91/181
Fibrinogen N
G3 Coagulation NT
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Siemens Thrombin 4 100.0 0.0 0.0 2.32 6.5 e*
2 Other methods 12 100.0 0.0 0.0 2.40 7.1 e*
3 Stago/STA 8 100.0 0.0 0.0 2.70 3.8 e
1.90 2.05 2.20 2.35 2.50 2.65 2.80 2.95 3.10 3.25 3.40
Fibrinogen N (g/l)
1
2
3
MQ 2015/1 Page 92/181
aPTT N
G3 Coagulation NT
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Actin FS 9 100.0 0.0 0.0 27.0 6.3 e
2 Other methods 13 100.0 0.0 0.0 27.0 8.7 e
3 Stago/STA 6 100.0 0.0 0.0 32.3 5.0 e
15 18 21 24 27 30 33 36 39 42 45
aPTT N (Sek)
1
2
3
MQ 2015/1 Page 93/181
Prothrombin time HT
G4 Coagulation heparine
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Neoplastin R 6 100.0 0.0 0.0 97 1.5 e
2 Innovin 8 100.0 0.0 0.0 92 6.6 e*
3 Recombiplastin IL 5 100.0 0.0 0.0 100 0.9 e
70 75 80 85 90 95 100 105 110 115 120
Prothrombin time HT (%)
1
2
3
MQ 2015/1 Page 94/181
Fibrinogen H
G4 Coagulation heparine
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Siemens Thrombin 4 75.0 0.0 25.0 2.97 6.5 e*
2 Other methods 10 100.0 0.0 0.0 3.11 5.4 e
3 Stago/STA 6 100.0 0.0 0.0 3.31 3.0 e
2.40 2.55 2.70 2.85 3.00 3.15 3.30 3.45 3.60 3.75 3.90
Fibrinogen H (g/l)
1
2
3
MQ 2015/1 Page 95/181
aPTT H
G4 Coagulation heparine
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Actin FS 7 100.0 0.0 0.0 60.8 9.5 e*
2 Other methods 10 80.0 20.0 0.0 72.9 16.9 e*
3 Stago/STA 4 100.0 0.0 0.0 86.1 18.5 e*
40 48 56 64 72 80 88 96 104 112 120
aPTT H (Sek)
1
2
3
MQ 2015/1 Page 96/181
Troponin I
K5 Cardiac Markers
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Vidas 6 100.0 0.0 0.0 15.6 5.7 e
2 AQT 90 FLEX 5 100.0 0.0 0.0 0.7 6.4 e
3 ADVIA Centaur XP/CP 6 100.0 0.0 0.0 4.4 12.1 e*
4 Eurolyser 11 45.4 9.1 45.5 3.0 18.8 e*
0.0 2.1 4.2 6.3 8.4 10.5 12.6 14.7 16.8 18.9 21.0
Troponin I (µg/l)
1
2
3
4
MQ 2015/1 Page 97/181
Troponin T
K5 Cardiac Markers
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas hs 5 100.0 0.0 0.0 1.99 12.1 e*
2 Cobas hs STAT 5 100.0 0.0 0.0 2.02 1.0 e
1.40 1.52 1.64 1.76 1.88 2.00 2.12 2.24 2.36 2.48 2.60
Troponin T (µg/l)
1
2
MQ 2015/1 Page 98/181
Myoglobin
K5 Cardiac Markers
QUALAB tolerance : 30 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 350.5 3.8 e
200 230 260 290 320 350 380 410 440 470 500
Myoglobin (µg/l)
1
MQ 2015/1 Page 99/181
D-dimer
G6 D-dimer
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas (Zitratplasma) 4 100.0 0.0 0.0 1.50 1.8 e
2 STA Liatest 7 100.0 0.0 0.0 1.47 4.1 e
3 Eurolyser 20 85.0 0.0 15.0 0.68 10.3 e
4 ACL 4 100.0 0.0 0.0 2.21 5.1 e*
5 AQT 90 FLEX 6 100.0 0.0 0.0 0.84 7.1 e*
6 Vidas 10 100.0 0.0 0.0 1.48 8.6 e*
0.0 0.3 0.6 0.9 1.2 1.5 1.8 2.1 2.4 2.7 3.0
D-dimer (mg/l)
1
2
3
4
5
6
MQ 2015/1 Page 100/181
D-Dimer NC
G5 D-Dimer NC
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 NycoCard 50 62.0 0.0 38.0 0.50 14.9 e
0.35 0.38 0.41 0.44 0.47 0.50 0.53 0.56 0.59 0.62 0.65
D-Dimer NC (mg/l)
1
MQ 2015/1 Page 101/181
TSH
K6 Hormones
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas E / Elecsys 10 100.0 0.0 0.0 12.0 3.0 e
2 ADVIA Centaur XP/CP 5 100.0 0.0 0.0 10.3 4.9 e
3 Architect 7 100.0 0.0 0.0 10.2 2.8 e
4 Vidas 9 100.0 0.0 0.0 12.5 6.6 e
5 Other methods 4 75.0 0.0 25.0 10.0 14.1 e*
6 Qualigen 4 75.0 25.0 0.0 8.9 12.5 e*
6 7 8 9 10 11 12 13 14 15 16
TSH (mU/l)
1
2
3
4
5
6
MQ 2015/1 Page 102/181
T3
K6 Hormones
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas E / Elecsys 4 100.0 0.0 0.0 3.4 1.6 e
2.50 2.66 2.82 2.98 3.14 3.30 3.46 3.62 3.78 3.94 4.10
T3 (nmol/l)
1
MQ 2015/1 Page 103/181
FT3
K6 Hormones
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas E / Elecsys 10 100.0 0.0 0.0 11.3 3.7 e
2 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 9.1 2.3 e
3 Architect 6 100.0 0.0 0.0 8.4 6.5 e*
4 Vidas 4 100.0 0.0 0.0 10.2 7.8 e*
6.0 6.8 7.6 8.4 9.2 10.0 10.8 11.6 12.4 13.2 14.0
FT3 (pmol/l)
1
2
3
4
MQ 2015/1 Page 104/181
FT4
K6 Hormones
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas E / Elecsys 11 100.0 0.0 0.0 34.5 3.9 e
2 ADVIA Centaur XP 4 100.0 0.0 0.0 23.7 6.6 e*
3 Architect 7 100.0 0.0 0.0 28.9 4.3 e
4 Vidas 6 100.0 0.0 0.0 33.2 3.9 e
5 Other methods 4 100.0 0.0 0.0 30.7 9.6 e*
15 18 21 24 27 30 33 36 39 42 45
FT4 (pmol/l)
1
2
3
4
5
MQ 2015/1 Page 105/181
Cortisol
K6 Hormones
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas E / Elecsys 6 100.0 0.0 0.0 651 4.3 e
2 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 571 10.2 e*
400 440 480 520 560 600 640 680 720 760 800
Cortisol (nmol/l)
1
2
MQ 2015/1 Page 106/181
Luteinizing hormone
K6 Hormones
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 32.0 8.5 e*
20.0 22.1 24.2 26.3 28.4 30.5 32.6 34.7 36.8 38.9 41.0
Luteinizing hormone (U/l)
1
MQ 2015/1 Page 107/181
Follicle-stimulating hormone
K6 Hormones
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 24.6 9.8 e*
18.0 19.5 21.0 22.5 24.0 25.5 27.0 28.5 30.0 31.5 33.0
Follicle-stimulating hormone (U/l)
1
MQ 2015/1 Page 108/181
Prolactine
K6 Hormones
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 19.6 12.2 e*
14.0 15.1 16.2 17.3 18.4 19.5 20.6 21.7 22.8 23.9 25.0
Prolactine (µg/l)
1
MQ 2015/1 Page 109/181
Troponin T CR
K8 Cardiac Reader/h232
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas h 232 746 97.4 1.9 0.7 0.29 9.5 e
2 Cardiac Reader 67 83.6 14.9 1.5 0.29 14.1 e
0.15 0.18 0.21 0.24 0.27 0.30 0.33 0.36 0.39 0.42 0.45
Troponin T CR (µg/l)
1
2
MQ 2015/1 Page 110/181
Troponin I WB
K8 Cardiac Reader/h232
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 iStat 4 100.0 0.0 0.0 6.19 9.9 e*
4.0 4.4 4.8 5.2 5.6 6.0 6.4 6.8 7.2 7.6 8.0
Troponin I WB (µg/l)
1
MQ 2015/1 Page 111/181
Myoglobin CR
K8 Cardiac Reader/h232
QUALAB tolerance : 30 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas h 232 4 100.0 0.0 0.0 700.0 0.0 e
400 460 520 580 640 700 760 820 880 940 1000
Myoglobin CR (µg/l)
1
MQ 2015/1 Page 112/181
D-dimer CR
K8 Cardiac Reader/h232
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas h 232 766 96.7 2.1 1.2 0.13 14.9 a
2 Cardiac Reader 60 98.3 1.7 0.0 0.14 15.0 a
0.080 0.092 0.104 0.116 0.128 0.140 0.152 0.164 0.176 0.188 0.200
D-dimer CR (mg/l)
1
2
MQ 2015/1 Page 113/181
CKMB - K8
K8 Cardiac Reader/h232
QUALAB tolerance : 40 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas h 232 7 100.0 0.0 0.0 7.5 6.9 e
4.0 4.7 5.4 6.1 6.8 7.5 8.2 8.9 9.6 10.3 11.0
CKMB - K8 (µg/l)
1
MQ 2015/1 Page 114/181
NT-proBNP CR
K8 Cardiac Reader/h232
QUALAB tolerance : 27 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas h 232 478 95.4 3.6 1.0 915 12.0 e
2 Cardiac Reader 22 81.8 9.1 9.1 915 13.8 e
500 580 660 740 820 900 980 1060 1140 1220 1300
NT-proBNP CR (ng/l)
1
2
MQ 2015/1 Page 115/181
PCO2 CCA
K9 Blood Gases AVL Opti CCA
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 OPTI CCA 14 100.0 0.0 0.0 5.85 4.6 e
5.00 5.17 5.34 5.51 5.68 5.85 6.02 6.19 6.36 6.53 6.70
PCO2 CCA (kPa)
1
MQ 2015/1 Page 116/181
PO2 CCA
K9 Blood Gases AVL Opti CCA
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 OPTI CCA 14 92.9 0.0 7.1 14.16 7.3 e*
11.0 11.6 12.2 12.8 13.4 14.0 14.6 15.2 15.8 16.4 17.0
PO2 CCA (kPa)
1
MQ 2015/1 Page 117/181
pH CCA
K9 Blood Gases AVL Opti CCA
QUALAB tolerance : 1 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 OPTI CCA 14 100.0 0.0 0.0 7.42 0.2 e
7.340 7.355 7.370 7.385 7.400 7.415 7.430 7.445 7.460 7.475 7.490
pH CCA ()
1
MQ 2015/1 Page 118/181
Potassium CCA
K9 Blood Gases AVL Opti CCA
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 OPTI CCA 8 100.0 0.0 0.0 4.7 1.1 e
4.30 4.38 4.46 4.54 4.62 4.70 4.78 4.86 4.94 5.02 5.10
Potassium CCA (mmol/l)
1
MQ 2015/1 Page 119/181
Sodium CCA
K9 Blood Gases AVL Opti CCA
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 OPTI CCA 7 100.0 0.0 0.0 144.0 0.8 e
134 136 138 140 142 144 146 148 150 152 154
Sodium CCA (mmol/l)
1
MQ 2015/1 Page 120/181
Ferritin
K10 Anemia
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 5 80.0 0.0 20.0 202.00 14.0 e*
2 Cobas E / Elecsys 11 100.0 0.0 0.0 196.51 8.5 e
3 Architect 4 100.0 0.0 0.0 246.85 5.0 e
4 Mira/DiaSys 4 100.0 0.0 0.0 173.00 7.4 e*
5 Mini Vidas 4 100.0 0.0 0.0 176.75 4.6 e
6 Eurolyser 22 86.4 13.6 0.0 140.30 17.1 e*
80 105 130 155 180 205 230 255 280 305 330
Ferritin (µg/l)
1
2
3
4
5
6
MQ 2015/1 Page 121/181
Vitamin B12
K10 Anemia
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ADVIA Centaur XP/CP 5 80.0 20.0 0.0 350.00 13.2 e*
2 Cobas E / Elecsys 7 100.0 0.0 0.0 366.00 1.9 e
3 Architect 5 100.0 0.0 0.0 355.00 6.7 e*
250 271 292 313 334 355 376 397 418 439 460
Vitamin B12 (pmol/l)
1
2
3
MQ 2015/1 Page 122/181
Folate
K10 Anemia
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ADVIA Centaur XP 4 100.0 0.0 0.0 10.20 9.7 e*
2 Cobas E / Elecsys 7 100.0 0.0 0.0 15.27 6.0 e
3 Architect 5 80.0 20.0 0.0 16.77 11.6 e*
7.0 8.5 10.0 11.5 13.0 14.5 16.0 17.5 19.0 20.5 22.0
Folate (nmol/l)
1
2
3
MQ 2015/1 Page 123/181
BNP
K11 BNP
QUALAB tolerance : 27 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Triage Meter 42 92.8 2.4 4.8 341.3 14.4 e
200 225 250 275 300 325 350 375 400 425 450
BNP (ng/l)
1
MQ 2015/1 Page 124/181
G10 INR INRatio
INR INRatio University Hospital Zuerich
INRatio Participants
G10 is a split-sample survey. We compare INR-values from our participans with the corresponding plasma INR from University Hospital Zuerich. Nr. Device Total % good % insufficient % outlier
1 INRatio 63 90.48 1.59 7.94
MQ 2015/1 Seite 125/181
Bilirubin total Neo
K12 Neonatal Bilirubin
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 11 100.0 0.0 0.0 98 5.9 e
75 80 85 90 95 100 105 110 115 120 125
Bilirubin total Neo (µmol/l)
1
MQ 2015/1 Page 126/181
Bilirubin direct
K12 Neonatal Bilirubin
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 13 92.3 0.0 7.7 50 7.0 e
39.0 41.1 43.2 45.3 47.4 49.5 51.6 53.7 55.8 57.9 60.0
Bilirubin direct (µmol/l)
1
MQ 2015/1 Page 127/181
Bilirubin neonatal
K12 Neonatal Bilirubin
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 6 83.3 16.7 0.0 136 10.3 e*
100 107 114 121 128 135 142 149 156 163 170
Bilirubin neonatal (µmol/l)
1
MQ 2015/1 Page 128/181
CK-MB
K15 Creatinkinase Activity
QUALAB tolerance : 30 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Fuji Dri-Chem 41 95.1 0.0 4.9 52.7 6.9 e
30.0 34.5 39.0 43.5 48.0 52.5 57.0 61.5 66.0 70.5 75.0
CK-MB (U/l)
1
MQ 2015/1 Page 129/181
PSA
K14 Tumor Markers
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas E / Elecsys 9 100.0 0.0 0.0 4.50 2.0 e
2 ADVIA Centaur XP/CP 5 100.0 0.0 0.0 3.40 4.4 e
3 Architect 5 100.0 0.0 0.0 3.79 2.6 e
4 Qualigen 5 100.0 0.0 0.0 4.70 8.0 e*
2.00 2.45 2.90 3.35 3.80 4.25 4.70 5.15 5.60 6.05 6.50
PSA (µg/l)
1
2
3
4
MQ 2015/1 Page 130/181
free PSA
K14 Tumor Markers
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas E / Elecsys 5 100.0 0.0 0.0 1.00 5.3 e
2 Architect 4 100.0 0.0 0.0 0.83 5.6 e
0.50 0.58 0.66 0.74 0.82 0.90 0.98 1.06 1.14 1.22 1.30
free PSA (µg/l)
1
2
MQ 2015/1 Page 131/181
CEA
K14 Tumor Markers
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas E / Elecsys 5 100.0 0.0 0.0 22.5 6.5 e
2 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 32.6 2.4 e
3 Architect 4 100.0 0.0 0.0 34.6 6.6 e*
10 14 18 22 26 30 34 38 42 46 50
CEA (µg/l)
1
2
3
MQ 2015/1 Page 132/181
CA 125
K14 Tumor Markers
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Architect 4 100.0 0.0 0.0 204.8 6.3 e*
140 153 166 179 192 205 218 231 244 257 270
CA 125 (kIU/l)
1
MQ 2015/1 Page 133/181
CA 15-3
K14 Tumor Markers
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Architect 4 100.0 0.0 0.0 20.4 3.9 e
14.0 15.3 16.6 17.9 19.2 20.5 21.8 23.1 24.4 25.7 27.0
CA 15-3 (kIU/l)
1
MQ 2015/1 Page 134/181
HCG qn
K14 Tumor Markers
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas E / Elecsys 5 100.0 0.0 0.0 17 6.8 e*
2 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 9 11.0 e*
3 Vidas 4 100.0 0.0 0.0 2 6.7 e*
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0
HCG qn (U/l)
1
2
3
MQ 2015/1 Page 135/181
pH OR
K16 Blood Gases Radiometer
QUALAB tolerance : 1 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 80 100.0 0.0 0.0 7.40 0.1 e
2 Radiometer NPT-7 6 100.0 0.0 0.0 7.43 0.2 e
3 ABL 90 24 100.0 0.0 0.0 7.40 0.1 e
4 ABL 80 / Coox 13 100.0 0.0 0.0 7.40 0.3 e
5 ABL 5 6 100.0 0.0 0.0 7.40 0.0 e
7.30 7.32 7.34 7.36 7.38 7.40 7.42 7.44 7.46 7.48 7.50
pH OR ()
1
2
3
4
5
MQ 2015/1 Page 136/181
pCO2 OR
K16 Blood Gases Radiometer
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 79 98.7 1.3 0.0 5.38 2.6 e
2 Radiometer NPT-7 6 100.0 0.0 0.0 5.79 2.5 e
3 ABL 90 24 100.0 0.0 0.0 5.51 1.9 e
4 ABL 80 / Coox 13 100.0 0.0 0.0 5.70 6.3 e*
5 ABL 5 6 100.0 0.0 0.0 5.48 1.2 e
4.50 4.75 5.00 5.25 5.50 5.75 6.00 6.25 6.50 6.75 7.00
pCO2 OR (kPa)
1
2
3
4
5
MQ 2015/1 Page 137/181
pO2 OR
K16 Blood Gases Radiometer
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 80 97.5 2.5 0.0 15.15 4.9 e
2 Radiometer NPT-7 6 100.0 0.0 0.0 14.36 2.9 e
3 ABL 90 24 91.6 4.2 4.2 13.52 5.8 e
4 ABL 80 / Coox 13 92.3 0.0 7.7 13.91 7.5 e*
5 ABL 5 6 100.0 0.0 0.0 14.10 3.6 e
10 11 12 13 14 15 16 17 18 19 20
pO2 OR (kPa)
1
2
3
4
5
MQ 2015/1 Page 138/181
ctHb OR
K16 Blood Gases Radiometer
QUALAB tolerance : 9 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 72 79.2 0.0 20.8 131.0 1.6 a
2 Radiometer NPT-7 4 75.0 0.0 25.0 200.5 1.4 e
3 ABL 90 22 100.0 0.0 0.0 129.9 0.9 e
4 ABL 80 / Coox 9 100.0 0.0 0.0 130.0 1.6 e
100 115 130 145 160 175 190 205 220 235 250
ctHb OR (g/l)
1
2
3
4
MQ 2015/1 Page 139/181
sO2 OR
K16 Blood Gases Radiometer
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 54 100.0 0.0 0.0 97.223 0.2 e
2 ABL 90 22 100.0 0.0 0.0 97.168 0.1 e
3 ABL 80 / Coox 9 100.0 0.0 0.0 97.200 0.4 e
70 75 80 85 90 95 100 105 110 115 120
sO2 OR (%)
1
2
3
MQ 2015/1 Page 140/181
FO2Hb OR
K16 Blood Gases Radiometer
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 50 100.0 0.0 0.0 91.988 0.2 e
2 Radiometer NPT-7 5 80.0 0.0 20.0 49.000 0.0 e
3 ABL 90 22 100.0 0.0 0.0 92.150 0.1 e
4 ABL 80 / Coox 9 100.0 0.0 0.0 92.200 0.1 e
30 39 48 57 66 75 84 93 102 111 120
FO2Hb OR (%)
1
2
3
4
MQ 2015/1 Page 141/181
FCOHb OR
K16 Blood Gases Radiometer
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 51 96.1 3.9 0.0 3.394 8.8 e
2 Radiometer NPT-7 5 80.0 0.0 20.0 20.000 0.2 e
3 ABL 90 22 100.0 0.0 0.0 3.200 4.3 e
4 ABL 80 / Coox 9 88.9 0.0 11.1 3.200 5.5 e
0 3 6 9 12 15 18 21 24 27 30
FCOHb OR (%)
1
2
3
4
MQ 2015/1 Page 142/181
FMetHb OR
K16 Blood Gases Radiometer
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 52 94.3 3.8 1.9 1.986 6.2 e
2 Radiometer NPT-7 5 80.0 0.0 20.0 10.000 0.0 e
3 ABL 90 22 95.5 0.0 4.5 1.924 2.8 e
4 ABL 80 / Coox 9 100.0 0.0 0.0 2.000 6.3 e
0.0 1.5 3.0 4.5 6.0 7.5 9.0 10.5 12.0 13.5 15.0
FMetHb OR (%)
1
2
3
4
MQ 2015/1 Page 143/181
FHbF OR
K16 Blood Gases Radiometer
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL 90 6 100.0 0.0 0.0 84.000 1.8 e
2 ABL 80 / Coox 4 100.0 0.0 0.0 2.550 5.1 e*
0 11 22 33 44 55 66 77 88 99 110
FHbF OR (%)
1
2
MQ 2015/1 Page 144/181
Bilirubin OR
K16 Blood Gases Radiometer
QUALAB tolerance : 18 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 8 100.0 0.0 0.0 303.5 1.0 e
2 ABL 90 9 100.0 0.0 0.0 299.0 0.8 e
230 245 260 275 290 305 320 335 350 365 380
Bilirubin OR (µmol/l)
1
2
MQ 2015/1 Page 145/181
Potassium OR
K16 Blood Gases Radiometer
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 66 100.0 0.0 0.0 3.8 0.9 e
2 ABL 90 24 100.0 0.0 0.0 3.8 1.1 e
3 ABL 80 / Coox 6 100.0 0.0 0.0 3.8 0.9 e
3.50 3.56 3.62 3.68 3.74 3.80 3.86 3.92 3.98 4.04 4.10
Potassium OR (mmol/l)
1
2
3
MQ 2015/1 Page 146/181
Sodium OR
K16 Blood Gases Radiometer
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 65 100.0 0.0 0.0 140.4 0.6 e
2 ABL 90 24 100.0 0.0 0.0 141.3 0.4 e
3 ABL 80 / Coox 5 100.0 0.0 0.0 141.0 1.3 e
130.0 132.5 135.0 137.5 140.0 142.5 145.0 147.5 150.0 152.5 155.0
Sodium OR (mmol/l)
1
2
3
MQ 2015/1 Page 147/181
Calcium OR
K16 Blood Gases Radiometer
QUALAB tolerance : 12 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 66 100.0 0.0 0.0 0.54 3.1 e
2 ABL 90 24 95.8 0.0 4.2 0.53 1.0 e
3 ABL 80 / Coox 5 100.0 0.0 0.0 0.52 2.9 e
0.450 0.466 0.482 0.498 0.514 0.530 0.546 0.562 0.578 0.594 0.610
Calcium OR (mmol/l)
1
2
3
MQ 2015/1 Page 148/181
Choride OR
K16 Blood Gases Radiometer
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 56 100.0 0.0 0.0 97.67 1.1 e
2 ABL 90 24 100.0 0.0 0.0 97.17 0.5 e
3 ABL 80 / Coox 5 100.0 0.0 0.0 97.00 1.2 e
90.0 91.5 93.0 94.5 96.0 97.5 99.0 100.5 102.0 103.5 105.0
Choride OR (mmol/l)
1
2
3
MQ 2015/1 Page 149/181
Glucose OR
K16 Blood Gases Radiometer
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 67 98.5 0.0 1.5 5.8 2.1 e
2 ABL 90 24 100.0 0.0 0.0 5.7 1.9 e
5.00 5.15 5.30 5.45 5.60 5.75 5.90 6.05 6.20 6.35 6.50
Glucose OR (mmol/l)
1
2
MQ 2015/1 Page 150/181
Lactate OR
K16 Blood Gases Radiometer
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ABL700/800 Radiomete 69 97.2 1.4 1.4 1.70 3.1 e
2 ABL 90 24 100.0 0.0 0.0 1.65 3.9 e
1.40 1.45 1.50 1.55 1.60 1.65 1.70 1.75 1.80 1.85 1.90
Lactate OR (mmol/l)
1
2
MQ 2015/1 Page 151/181
BNP Plasma
K17 BNP Plasma
QUALAB tolerance : 27 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 ADVIA Centaur XP/CP 5 100.0 0.0 0.0 519.3 3.1 e
300 340 380 420 460 500 540 580 620 660 700
BNP Plasma (ng/l)
1
MQ 2015/1 Page 152/181
NT-proBNP
K17 BNP Plasma
QUALAB tolerance : 27 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 AQT 90 FLEX 5 100.0 0.0 0.0 1560.0 6.5 e
2 Cobas E / Elecsys 12 100.0 0.0 0.0 570.1 6.1 e
0 250 500 750 1000 1250 1500 1750 2000 2250 2500
NT-proBNP (ng/l)
1
2
MQ 2015/1 Page 153/181
Cholesterin PTS
K19 CardioChek Lipidpanel
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 CardioChek 5 60.0 40.0 0.0 7.4 9.3 e*
6.00 6.25 6.50 6.75 7.00 7.25 7.50 7.75 8.00 8.25 8.50
Cholesterin PTS (mmol/l)
1
MQ 2015/1 Page 154/181
Cholesterin HDL PTS
K19 CardioChek Lipidpanel
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 CardioChek 5 100.0 0.0 0.0 2.6 0.0 e
1.90 2.05 2.20 2.35 2.50 2.65 2.80 2.95 3.10 3.25 3.40
Cholesterin HDL PTS (mmol/l)
1
MQ 2015/1 Page 155/181
Triglyceride PTS
K19 CardioChek Lipidpanel
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 CardioChek 5 100.0 0.0 0.0 5.65 0.4 e
4.0 4.3 4.6 4.9 5.2 5.5 5.8 6.1 6.4 6.7 7.0
Triglyceride PTS (mmol/l)
1
MQ 2015/1 Page 156/181
Creatinine U
U5 Urine Albumin / ACR
QUALAB tolerance : 30 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Siemens Clinitek 11 72.7 9.1 18.2 80.0 13.4 a
2 Afinion 318 97.8 1.3 0.9 90.4 10.9 e
3 NycoCard 19 94.7 0.0 5.3 92.4 17.1 e*
4 Turbidimetry 13 100.0 0.0 0.0 84.2 4.8 e
5 DCA2000/Vantage 111 97.3 0.0 2.7 86.9 5.0 e
40 49 58 67 76 85 94 103 112 121 130
Creatinine U (mg/l)
1
2
3
4
5
MQ 2015/1 Page 157/181
Creatinin Urin
U5 Urine Albumin / ACR
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 DCA2000/Vantage 111 95.5 0.0 4.5 5.6 3.6 e
2 Afinion 318 98.8 0.6 0.6 5.0 5.7 e
3 Standard chemistry 23 100.0 0.0 0.0 5.4 5.4 e
4 Siemens Clinitek 9 66.7 0.0 33.3 8.8 5.3 e
3.0 3.8 4.6 5.4 6.2 7.0 7.8 8.6 9.4 10.2 11.0
Creatinin Urin (mmol/l)
1
2
3
4
MQ 2015/1 Page 158/181
INR CCXS
G11 CoaguChek XS INR
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 CoaguChek XS 2342 98.1 1.6 0.3 2.2 4.8 e
1.50 1.62 1.74 1.86 1.98 2.10 2.22 2.34 2.46 2.58 2.70
INR CCXS ()
1
MQ 2015/1 Page 159/181
INR HC
G12 Hemochron
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Hemochron j. 24 66.7 20.8 12.5 4.5 10.4 e*
3.5 3.7 3.9 4.1 4.3 4.5 4.7 4.9 5.1 5.3 5.5
INR HC ()
1
MQ 2015/1 Page 160/181
Osmolality
K22 Osmolality
QUALAB tolerance : 6 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cryoskopy 11 90.9 9.1 0.0 147 2.4 e*
135.0 137.5 140.0 142.5 145.0 147.5 150.0 152.5 155.0 157.5 160.0
Osmolality (mosm/kg)
1
MQ 2015/1 Page 161/181
Procalcitonin
K20 PCT
QUALAB tolerance : 27 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 16 100.0 0.0 0.0 2.08 10.7 e
2 Mini Vidas 10 100.0 0.0 0.0 2.87 8.8 e
1.0 1.3 1.6 1.9 2.2 2.5 2.8 3.1 3.4 3.7 4.0
Procalcitonin (µg/l)
1
2
MQ 2015/1 Page 162/181
Parathyroid hormone
K21 PTH / Vit. D
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas PTH STAT 5 100.0 0.0 0.0 37.4 2.0 e
25.0 27.5 30.0 32.5 35.0 37.5 40.0 42.5 45.0 47.5 50.0
Parathyroid hormone (pmol/l)
1
MQ 2015/1 Page 163/181
25-OH Vitamin D
K21 PTH / Vit. D
QUALAB tolerance : 27 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Qualigen 4 100.0 0.0 0.0 160.5 6.1 e
2 Cobas 7 100.0 0.0 0.0 153.1 7.9 e
3 Architect 4 100.0 0.0 0.0 135.9 9.7 e*
90 102 114 126 138 150 162 174 186 198 210
25-OH Vitamin D (nmol/l)
1
2
3
MQ 2015/1 Page 164/181
Digoxin
K24 Drug Monitoring
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Other methods 11 100.0 0.0 0.0 2.62 9.4 e
1.90 2.05 2.20 2.35 2.50 2.65 2.80 2.95 3.10 3.25 3.40
Digoxin (nmol/l)
1
MQ 2015/1 Page 165/181
Valproat
K24 Drug Monitoring
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 5 80.0 20.0 0.0 532.0 11.8 e*
350 390 430 470 510 550 590 630 670 710 750
Valproat (µmol/l)
1
MQ 2015/1 Page 166/181
Hematocrit
H5 Hematology BG
QUALAB tolerance : 9 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 EPOC 4 50.0 25.0 25.0 0.32 7.5 e*
0.27 0.28 0.29 0.30 0.31 0.32 0.33 0.34 0.35 0.36 0.37
Hematocrit (l/l)
1
MQ 2015/1 Page 167/181
Troponin Triage
K26 Cardiac Triage
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Triage Meter 37 64.9 8.1 27.0 3.55 14.0 e
2.5 2.7 2.9 3.1 3.3 3.5 3.7 3.9 4.1 4.3 4.5
Troponin Triage (µg/l)
1
MQ 2015/1 Page 168/181
D-dimer Triage
K26 Cardiac Triage
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Triage Meter 35 97.1 0.0 2.9 100.00 0.0 e
70 76 82 88 94 100 106 112 118 124 130
D-dimer Triage (ng/ml)
1
MQ 2015/1 Page 169/181
CK-MB Triage
K26 Cardiac Triage
QUALAB tolerance : 40 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Triage Meter 22 90.9 0.0 9.1 3.2 14.2 e
1.50 1.85 2.20 2.55 2.90 3.25 3.60 3.95 4.30 4.65 5.00
CK-MB Triage (µg/l)
1
MQ 2015/1 Page 170/181
Myoglobin Triage
K26 Cardiac Triage
QUALAB tolerance : 30 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Triage Meter 20 95.0 0.0 5.0 491.3 3.3 e
300 340 380 420 460 500 540 580 620 660 700
Myoglobin Triage (µg/l)
1
MQ 2015/1 Page 171/181
Ethanol
K28 Ethanol
QUALAB tolerance : 25 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 all Participants 5 100.0 0.0 0.0 21.8 5.2 e
15.0 16.5 18.0 19.5 21.0 22.5 24.0 25.5 27.0 28.5 30.0
Ethanol (mmol/l)
1
MQ 2015/1 Page 172/181
Calprotectin
K29 Calprotectin
QUALAB tolerance : 40 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Bühlmann 7 85.7 14.3 0.0 191 29.4 e*
70 95 120 145 170 195 220 245 270 295 320
Calprotectin (µg/g)
1
MQ 2015/1 Page 173/181
Cholesterol total Af/b101
K30 Lipids Af / b101
QUALAB tolerance : 10 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b101 24 100.0 0.0 0.0 4.8 1.8 e
2 Afinion 224 98.7 0.9 0.4 4.9 3.5 e
4.20 4.35 4.50 4.65 4.80 4.95 5.10 5.25 5.40 5.55 5.70
Cholesterol total Af/b101 (mmol/l)
1
2
MQ 2015/1 Page 174/181
Cholesterol HDL Af/b101
K30 Lipids Af / b101
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b101 24 91.7 0.0 8.3 1.4 2.8 e
2 Afinion 225 92.0 0.0 8.0 1.0 4.2 e
0.70 0.81 0.92 1.03 1.14 1.25 1.36 1.47 1.58 1.69 1.80
Cholesterol HDL Af/b101 (mmol/l)
1
2
MQ 2015/1 Page 175/181
Tryglycerides Af/b101
K30 Lipids Af / b101
QUALAB tolerance : 20 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Cobas b101 24 100.0 0.0 0.0 1.82 1.6 e
2 Afinion 223 100.0 0.0 0.0 1.64 3.8 e
1.20 1.31 1.42 1.53 1.64 1.75 1.86 1.97 2.08 2.19 2.30
Tryglycerides Af/b101 (mmol/l)
1
2
MQ 2015/1 Page 176/181
Troponin I S
K31 Samsung IB 10
QUALAB tolerance : 24 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Samsung LABGEO IB10 68 72.1 23.5 4.4 8.07 18.7 e
5.0 5.7 6.4 7.1 7.8 8.5 9.2 9.9 10.6 11.3 12.0
Troponin I S (µg/l)
1
MQ 2015/1 Page 177/181
D-dimer qn S
K31 Samsung IB 10
QUALAB tolerance : 21 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Samsung LABGEO IB10 80 97.4 1.3 1.3 1.48 6.9 e
1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 2.0
D-dimer qn S (mg/l)
1
MQ 2015/1 Page 178/181
NT-pro BNP S
K31 Samsung IB 10
QUALAB tolerance : 27 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Samsung LABGEO IB10 56 100.0 0.0 0.0 1984.3 11.4 e
1300 1450 1600 1750 1900 2050 2200 2350 2500 2650 2800
NT-pro BNP S (ng/l)
1
MQ 2015/1 Page 179/181
INR MI
G14 MicroINR
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 microINR 64 68.7 17.2 14.1 1.8 9.8 e
1.4 1.5 1.6 1.7 1.8 1.9 2.0 2.1 2.2 2.3 2.4
INR MI ()
1
MQ 2015/1 Page 180/181
INR Eurolyser
G15 INR Eurolyser
QUALAB tolerance : 15 %
No.Methode Total % good % insuff. % outlier Target value CV% Typ
1 Eurolyser 7 85.7 14.3 0.0 1.0 9.1 e*
0.80 0.85 0.90 0.95 1.00 1.05 1.10 1.15 1.20 1.25 1.30
INR Eurolyser ()
1
MQ 2015/1 Page 181/181